Cargando…
Development and Validation of the Medical Affairs Pharmaceutical Physician Value (MAPPval) Instrument
BACKGROUND: A pilot study conducted in 2020 suggested that Medical Affairs Pharmaceutical Physicians (MAPPs) may be inherently undervalued within the pharmaceutical industry and vulnerable to replacement by less qualified roles. There are currently no standardized metrics to measure MAPP performance...
Autor principal: | Jandhyala, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818008/ https://www.ncbi.nlm.nih.gov/pubmed/34994965 http://dx.doi.org/10.1007/s40290-021-00413-9 |
Ejemplares similares
-
Professional qualifications of medical affairs pharmaceutical physicians and other internal stakeholders in the pharmaceutical industry
por: Jandhyala, Ravi
Publicado: (2022) -
Development of a Definition for Medical Affairs Using the Jandhyala Method for Observing Consensus Opinion Among Medical Affairs Pharmaceutical Physicians
por: Jandhyala, Ravi
Publicado: (2022) -
Design, validation and implementation of the post-acute (long) COVID-19 quality of life (PAC-19QoL) instrument
por: Jandhyala, Ravi
Publicado: (2021) -
Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan
por: Maeda, Hideki
Publicado: (2021) -
Neutral theory: applicability and neutrality of clinical study endpoints where a disease-specific instrument is available
por: Jandhyala, Ravi
Publicado: (2023)